Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Adenine | HCID 190 | — |
| Reactant | Triisopropyl phosphite | HCID 8304 | — |
| Reactant | 7-Oxabicyclo[4.1.0]hept-2-ene | HCID 160866 | — |
| Reactant | Butyllithium | HCID 178418339 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | Hexane | HCID 8058 | — |
| Product | HCID 19047346 | HCID 19047346 | 36.9% |
Reaction Steps
The palladium(0) catalyst is prepared by bringing together 179.6 mg of palladium(II) acetate, 2 ml of triisopropyl phosphite and 1.06 ml of a 1.4 molar solution of butyllithium in n-hexane in 60 ml of dry tetrahydrofuran at 0° C. under argon. 60 ml of dry dimethylsulfoxide and 17.32 g (0.128 mol) of adenine are then added. After stirring for 15 minutes, 12.3 g (0.128 mol) of 3,4-epoxycyclohexene, dissolved in 40 ml of dry tetrahydrofuran, are added dropwise (3 hours). The suspension is stirred at room temperature for 24 hours, poured into 650 ml of ethanol and stirred and the precipitate (1 g of adenine) is filtered off with suction. The filtrate is concentrated and the residue is chromatographed over aluminum oxide using methylene chloride/methanol 15/1. 7.96 g (36.9% of theory) of 9-[(1RS,4SR)-4-hydroxycyclohex-2-en-1-yl]adenine of melting point 181° to 183° C. are obtained. 1H NMR (270 MHz, d6 -DMSO); δ[ppm]: 8.15 (s, 1H), 8.04 (s, 1H), 7.22 (s, 2H), 6.09 (m, 1H), 5.84 (m, 1H), 5.06 (m, 1H), 4.93 (d, 1H), 4.09 (m, 1H), 1.99 (m, 2H), 1.81 (m, 1H),, 1.56 (m, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05631259 |
|---|
| Source dataset | uspto-grants-1997_05 |
|---|
| ORD ID | ord-6e14b0ec78f34ee0b298c7c757c73c4b |
|---|
| Source note | uspto-grants-1997_05 |
|---|